SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Jozwiak Sergiusz)
 

Sökning: WFRF:(Jozwiak Sergiusz) > (2019) > Advancing research ...

Advancing research toward faster diagnosis, better treatment, and end of stigma in epilepsy

Pitkänen, Asla (författare)
University of Eastern Finland
Henshall, David C. (författare)
Royal College of Surgeons in Ireland
Cross, J. Helen (författare)
University College London
visa fler...
Guerrini, Renzo (författare)
University of Florence,Meyer Children's Hospital
Jozwiak, Sergiusz (författare)
Medical University of Warsaw,Children’s Memorial Health Institute
Kokaia, Merab (författare)
Lund University,Lunds universitet,NanoLund: Centre for Nanoscience,Annan verksamhet, LTH,Lunds Tekniska Högskola,Experimentell Epilepsi,Forskargrupper vid Lunds universitet,Other operations, LTH,Faculty of Engineering, LTH,Experimental Epilepsy Group,Lund University Research Groups
Simonato, Michele (författare)
Vita-Salute San Raffaele University
Sisodiya, Sanjay (författare)
University College London
Mifsud, Janet (författare)
University of Malta
visa färre...
 (creator_code:org_t)
2019-06-18
2019
Engelska.
Ingår i: Epilepsia. - : Wiley. - 0013-9580 .- 1528-1167.
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Seven large European Union (EU)–funded epilepsy-related research projects joined forces in May 2018 in Brussels, Belgium, in a unique community building event—the epiXchange conference. During this conference, 170 investigators from the projects DESIRE, EpimiRNA, EPISTOP, EpiTarget, EpiXchange, and EpiPGX as well as the European Reference Network EpiCARE, met up with key stakeholders including representatives of the European Commission, patient organizations, commercial partners, and other European and International groups. The epiXchange conference focused on sharing and reviewing the advances made by each project in the previous 5 years; describing the infrastructures generated; and discussing the innovations and commercial applications across five thematic areas: biomarkers, genetics, therapeutics, comorbidities, and biobanks and resources. These projects have, in fact, generated major breakthroughs including the discovery of biofluid-based molecules for diagnosis, elucidating new genetic causes of epilepsy, creating advanced new models of epilepsy, and the pre-clinical development of novel compounds. Workshop-style discussions focused on how to overcome scientific and clinical challenges for accelerating translation of research outcomes and how to increase synergies between the projects and stakeholders at a European level. The resulting advances would lead toward a measurable impact of epilepsy research through better diagnostics, treatments, and quality-of-life for persons with epilepsy. In addition, epiXchange provided a unique forum for examining how the different projects could build momentum for future novel groundbreaking epilepsy research in Europe and beyond. This report includes the main recommendations that resulted from these discussions.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Neurologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Neurology (hsv//eng)

Nyckelord

biobanks
biomarker
comorbidities
databases
delivery systems
disease-modification
e-health
epileptogenesis
genetics
personalized medicine
research strategy
stigma
therapy

Publikations- och innehållstyp

art (ämneskategori)
ref (ämneskategori)

Hitta via bibliotek

  • Epilepsia (Sök värdpublikationen i LIBRIS)

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy